This study is limited by the built-in shortage of no information of laboratory data (such as alpha-fetoprotein), and radiographic and pathological findings regarding tumor status in the claim database, which impedes the risk factor analysis between recurrence and non-recurrence. This evidence concerns the gene AFP and neoplasm.